{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:05:16Z","timestamp":1792699516811,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1461600"],"award-info":[{"award-number":["22ZR1461600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["YY29AQ8CSV"],"award-info":[{"award-number":["YY29AQ8CSV"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["AS29AQ4311"],"award-info":[{"award-number":["AS29AQ4311"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["IS29AKQS9W"],"award-info":[{"award-number":["IS29AKQS9W"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["PB29AKQ7IM"],"award-info":[{"award-number":["PB29AKQ7IM"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["WB29AKPGQM"],"award-info":[{"award-number":["WB29AKPGQM"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["CI29AQA1SR"],"award-info":[{"award-number":["CI29AQA1SR"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["A2-X1904426"],"award-info":[{"award-number":["A2-X1904426"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbcan.2026.189566","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:08:46Z","timestamp":1772125726000},"page":"189566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mechanisms"],"prefix":"10.1016","volume":"1881","author":[{"given":"Linlin","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbcan.2026.189566_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112798","article-title":"Emerging therapies for hepatocellular carcinoma (HCC)","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12672-024-01002-3","article-title":"The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Discov. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189566_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101377","article-title":"DDR2\/STAT3 positive feedback loop mediates the immunosuppressive microenvironment by upregulating PD-L1 and recruiting MDSCs in oxaliplatin-resistant HCC","volume":"18","author":"Liu","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189566_bb0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90911","article-title":"Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma","volume":"12","author":"Zhao","year":"2024","journal-title":"Elife"},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2026.189566_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000481243","article-title":"Transarterial chemoembolization in combination with a molecular targeted agent: lessons learned from negative trials (post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2)","volume":"93","author":"Kudo","year":"2017","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189566_bb0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189566_bb0035","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189566_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031456","article-title":"New opportunities in the systemic treatment of hepatocellular carcinoma-today and tomorrow","volume":"25","author":"Becht","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189566_bb0050","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/thno.54822","article-title":"Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma","volume":"11","author":"Kong","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189566_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bbcan.2026.189566_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991052","article-title":"Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: mechanistic insights","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2026.189566_bb0065","article-title":"Advancing glioblastoma treatment through iron metabolism: a focus on TfR1 and ferroptosis innovations","volume":"278","author":"Caverzan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189566_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189566_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12032-024-02317-5","article-title":"Ferroptosis is an effective strategy for cancer therapy","volume":"41","author":"Khan","year":"2024","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-024-00560-2","article-title":"Role of ferroptosis and ferroptosis-related long non\u2019coding RNA in breast cancer","volume":"29","author":"Xiang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189566_bb0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189566_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179271","article-title":"Overview of ferroptosis and synthetic lethality strategies","volume":"22","author":"Kinowaki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189566_bb0105","doi-asserted-by":"crossref","first-page":"1207496","DOI":"10.3389\/fphar.2023.1207496","article-title":"Mechanism of sorafenib resistance associated with ferroptosis in HCC","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.gendis.2020.09.005","article-title":"Ferroptosis: an emerging therapeutic opportunity for cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Genes Dis."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189566_bb0115","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","article-title":"ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma","volume":"23","author":"Huang","year":"2021","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189566_bb0120","first-page":"3106","article-title":"SLC7A11\/xCT in cancer: biological functions and therapeutic implications","volume":"10","author":"Lin","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S2468-1253(25)00059-7","article-title":"Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial","volume":"10","author":"Shi","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189566_bb0130","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.18632\/aging.103378","article-title":"Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1","volume":"12","author":"Dong","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189566_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"7545","key":"10.1016\/j.bbcan.2026.189566_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189566_bb0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41419-023-06311-z","article-title":"LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010587","article-title":"Role of SLC7A11\/xCT in ovarian cancer","volume":"25","author":"Fantone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189566_bb0165","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.21037\/atm-21-4863","article-title":"A narrative review of mechanisms of ferroptosis in cancer: new challenges and opportunities","volume":"9","author":"Jiang","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"7679","key":"10.1016\/j.bbcan.2026.189566_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189566_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.trsl.2024.05.007","article-title":"GPX4 transcriptionally promotes liver cancer metastasis via GRHL3\/PTEN\/PI3K\/AKT axis","volume":"271","author":"Pan","year":"2024","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0180","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","article-title":"HBx-induced HSPA8 stimulates HBV replication and suppresses ferroptosis to support liver cancer progression","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0185","article-title":"Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","article-title":"Ferroptosis in liver disease: new insights into disease mechanisms","volume":"7","author":"Wu","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189566_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101250","article-title":"Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis","volume":"81","author":"He","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12948","article-title":"Melatonin MT1 receptors regulate the Sirt1\/Nrf2\/Ho-1\/Gpx4 pathway to prevent \u03b1-synuclein-induced ferroptosis in Parkinson\u2019s disease","volume":"76","author":"Lv","year":"2024","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbcan.2026.189566_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110594","article-title":"Sodium hydrosulfide inhibits hemin-induced ferroptosis and lipid peroxidation in BV2 cells via the CBS\/H(2)S system","volume":"104","author":"Yu","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2026.189566_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 system in cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2026.189566_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.105038","article-title":"Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of cisplatin and etoposide in NSCLC cells","volume":"70","author":"Fouzder","year":"2021","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bbcan.2026.189566_bb0225","doi-asserted-by":"crossref","first-page":"2915019","DOI":"10.1155\/2021\/2915019","article-title":"RSL3 drives ferroptosis through NF-\u03baB pathway activation and GPX4 depletion in glioblastoma","volume":"2021","author":"Li","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189566_bb0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00018-025-05812-8","article-title":"Ferroptosis in cancer: revealing the multifaceted functions of mitochondria","volume":"82","author":"Ding","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"7784","key":"10.1016\/j.bbcan.2026.189566_bb0240","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.bbcan.2026.189566_bb0245","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s13018-025-06315-9","article-title":"Ferroptosis-mediated osteoclast-osteoblast crosstalk: signaling pathways governing bone remodeling in osteoporosis","volume":"20","author":"Yang","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43556-022-00105-z","article-title":"The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach","volume":"3","author":"Zeng","year":"2022","journal-title":"Mol. Biomed."},{"issue":"7969","key":"10.1016\/j.bbcan.2026.189566_bb0260","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189566_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157450","article-title":"Arachidonic acid induces ferroptosis in hepatocellular carcinoma via the SIRT5-ACSL4\/LPCAT3\/ALOX15 axis, leading to lipid peroxidation and mitochondrial dysfunction","volume":"148","author":"Xue","year":"2025","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2009.12.002","article-title":"The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice","volume":"49","author":"Guillou","year":"2010","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbalip.2013.10.018","article-title":"Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol","volume":"1841","author":"K\u00fcch","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0280","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","article-title":"Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death","volume":"10","author":"Dixon","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"27","key":"10.1016\/j.bbcan.2026.189566_bb0290","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1021\/acs.jafc.5c00107","article-title":"Ginsenoside RK1 promotes hepatic stellate cell glycolysis-mediated ferroptosis by activating the HK2\/ACSL4\/LPCAT3\/ALOX5 Signaling pathway","volume":"73","author":"Xia","year":"2025","journal-title":"J. Agric. Food Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0295","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cac2.12319","article-title":"PKC\u03b2II-ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity","volume":"42","author":"Lei","year":"2022","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bbcan.2026.189566_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119532","article-title":"Gancao Xiexin decoction attenuated experimental colitis through suppressing ACSL4-mediated ferroptosis","volume":"344","author":"Pan","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189566_bb0305","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"issue":"44","key":"10.1016\/j.bbcan.2026.189566_bb0310","doi-asserted-by":"crossref","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","article-title":"Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses","volume":"113","author":"Ou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112724","article-title":"The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2","volume":"42","author":"Kre\u00df","year":"2023","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189566_bb0320","article-title":"Ferroptosis and Nrf2 signaling in head and neck cancer: resistance mechanisms and therapeutic prospects","volume":"14","author":"Lee","year":"2025","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189566_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0332761","article-title":"SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis","volume":"20","author":"Yang","year":"2025","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189566_bb0330","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18212","article-title":"SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation","volume":"28","author":"He","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189566_bb0335","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2 Pt B","key":"10.1016\/j.bbcan.2026.189566_bb0340","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.canlet.2014.11.014","article-title":"The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells","volume":"356","author":"Louandre","year":"2015","journal-title":"Cancer Lett."},{"issue":"70","key":"10.1016\/j.bbcan.2026.189566_bb0345","doi-asserted-by":"crossref","first-page":"114588","DOI":"10.18632\/oncotarget.23055","article-title":"CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2\u03b1-ATF4 pathway","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189566_bb0350","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.bjc.6604485","article-title":"The xc- cystine\/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance","volume":"99","author":"Lo","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"49","key":"10.1016\/j.bbcan.2026.189566_bb0355","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0360","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-021-00226-1","article-title":"Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment","volume":"10","author":"Wang","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189566_bb0365","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2026.189566_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216021","article-title":"Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer","volume":"554","author":"Tang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0375","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12951-024-02713-z","article-title":"Advancing osteoarthritis therapy with GMOCS hydrogel-loaded BMSCs-exos","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189566_bb0380","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1566524022666220509124608","article-title":"Ferroptosis and cancer immunotherapy","volume":"23","author":"Yin","year":"2023","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189566_bb0385","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4254\/wjh.v11.i5.412","article-title":"Roles of hepatic stellate cells in acute liver failure: from the perspective of inflammation and fibrosis","volume":"11","author":"Li","year":"2019","journal-title":"World J. Hepatol."},{"issue":"7350","key":"10.1016\/j.bbcan.2026.189566_bb0390","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189566_bb0395","article-title":"Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: molecular mechanisms and therapeutic implications","volume":"45","author":"Das","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"issue":"7769","key":"10.1016\/j.bbcan.2026.189566_bb0400","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189566_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119399","article-title":"Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis","volume":"276","author":"Song","year":"2021","journal-title":"Life Sci."},{"issue":"7755","key":"10.1016\/j.bbcan.2026.189566_bb0410","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189566_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111785","article-title":"Nanoparticles for ferroptosis therapy in cancer","volume":"13","author":"Zaffaroni","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0420","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0425","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12575-023-00199-x","article-title":"TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC","volume":"25","author":"Tang","year":"2023","journal-title":"Biol. Proced Online"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0430","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189566_bb0435","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189566_bb0440","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189566_bb0445","doi-asserted-by":"crossref","first-page":"re2","DOI":"10.1091\/mbc.E24-12-0564","article-title":"Selective translation under heat shock: integrating HSP70 mRNA regulation with cellular stress responses in yeast and mammals","volume":"36","author":"Ghadanian","year":"2025","journal-title":"Mol. Biol. Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189566_bb0450","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.7150\/ijbs.59404","article-title":"Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells","volume":"17","author":"Wei","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189566_bb0455","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41419-020-2334-2","article-title":"Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure","volume":"11","author":"Yamada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"47","key":"10.1016\/j.bbcan.2026.189566_bb0460","doi-asserted-by":"crossref","first-page":"16836","DOI":"10.1073\/pnas.1415518111","article-title":"Synchronized renal tubular cell death involves ferroptosis","volume":"111","author":"Linkermann","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189566_bb0465","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189566_bb0470","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/annonc\/mdy101","article-title":"Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma","volume":"29","author":"Abou-Alfa","year":"2018","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189566_bb0475","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189566_bb0480","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1039\/D2TB02161G","article-title":"Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy","volume":"11","author":"Yin","year":"2023","journal-title":"J. Mater. Chem. B"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:42:25Z","timestamp":1782031345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304419X26000387"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189566","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189566"}}